1.MW 130kDa,special substitution0.4 2.Initial volume expansion is 100% 3.Factory direct, price advantage 4.GMP certificate
1.At present, the hydroxyethyl starch expansion of the low substitution and molecular weight in the clinical expansion treatment has been widely used. On this basis, the third generation of hydroxyethyl starch products--- hydroxyethyl starch130/0.4 shows new improvements in the physical and chemical properties, expansion effect and safety aspects, which has more potential applications.
2. The perfect combination of the molecular weight 130.000Da, spcial substitution 0.4 and C2/C6 ratio 9:1 makes 100% of plasma expansion effect and excellent safety.The molecular weight distribution is more concentrated.
4. Advantages of our products as follows: 100% of the initial volume effect and 4-6-hour plateau effect; good security; the beneficial effects on blood rheology (micro cycle); minimal impact on blood coagulation; no plasma accumulation, significantly reduced tissue accumulation; the security of a large dose(50 ml / kg); no effect on renal function; better improvement in oxygen delivery; children aged 0-2 is safe to use.
5.Our products are factory direct, long-term price advantage varieties, secure sources of raw materials and Long-term stable cooperation.
6. Molecular weight is absolute and accurate data. Our company uses TAL method to measure endotoxin, high sensitivity, good security.Therefore, our product Hydroxyethyl Starch 130/0.4 is the first choice in the treatment of colloid volume.
MF (C6H10O5)m(C2H5O)n Hydroxyethyl starch 130/0.4
